THYROCARE TECHNOLOGIES
Intrinsic Value | Fundamental Analysis

BOM : 539871     NSE : THYROCARE    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : High [>50%]
May 27,2022
Price(EOD): β‚Ή 690.95
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Hospital & Healthcare Services
MCap: β‚Ή 3,655.13 Cr
Value of β‚Ή 1 Lac invested in THYROCARE TECHNOLOGIES
on May 29,2017 (price: β‚Ή 705.70)

β‚Ή 1 L

β‚Ή 0.98 L

1W : 6.1% 1M : -15.6% 1Y : -31.1%
COMMUNITY POLL
for THYROCARE TECHNOLOGIES
Please provide your vote to see the results
THYROCARE TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Industry Peers & Returns1W1M1Y
THYROCARE TECHNOLOGIES 6.1% -15.6% -31.1%
APOLLO HOSPITALS ENTERPRISE 3.8% -14.6% 14.6%
MAX HEALTHCARE INSTITUTE 2.3% -9% 57.5%
DR LAL PATHLABS 11.4% -20.8% -27.4%
FORTIS HEALTHCARE -3.2% -13.9% 5.7%
METROPOLIS HEALTHCARE -5.3% -30% -30.6%
ASTER DM HEALTHCARE 13.4% 0.4% 28%
NARAYANA HRUDAYALAYA 3.5% -7.7% 51.9%
KRISHNA INSTITUTE OF MEDICAL SCIENCES -2% -3.8% NA

FUNDAMENTAL ANALYSIS OF THYROCARE TECHNOLOGIES

 
Fundamentals Score
[ Q(TTM): Mar2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights πŸ’‘ THYROCARE is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF THYROCARE TECHNOLOGIES

 
Valuation Score
[As on : May 27,2022 ]

Ratio Consolidated
P/E
P/B
P/S
32.29
P/E Calculated based on EPS of 21.4
[ Mar2021 - Consolidated Results ]

8.61
P/B Calculated based on Book Value of 80.26
[ Mar2021 - Consolidated Results ]

6.21
P/S Calculated based on Revenues of 588.82 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights πŸ’‘ THYROCARE is one of the potential top 21% undervalued companies ! Discover More →

FAIR VALUE OF THYROCARE TECHNOLOGIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-3%
-36%
-44%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF THYROCARE TECHNOLOGIES


Insights πŸ’‘ There are 5% companies with bullish price momentum currently! Discover More →

THYROCARE TECHNOLOGIES vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF THYROCARE TECHNOLOGIES

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0
0
0
-
0
0.01
0.01
0.01
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF THYROCARE TECHNOLOGIES

Pledged Promoter Shares
100 %
As on : Mar2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF THYROCARE TECHNOLOGIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
11.21%
2.15%
2.08%
-4.52%
-11.09%
-27.05%
-37.83%
-44.85%
QtrlyTrend
-2
Latest Qtr: Mar2022
Quarterly Result Analysis →


THYROCARE TECHNOLOGIES related INDICES

BSE Indices1W1M1Y
S&P BSE 500 -0.1% -6.8% 7.2%
S&P BSE ALLCAP -0.3% -7.1% 7.5%
S&P BSE 400 MIDSMALLCAP -1.3% -9.3% 7.2%
S&P BSE MIDSMALLCAP -1.5% -10.1% 7.1%
S&P BSE HEALTHCARE -2% -8.1% -8.7%
S&P BSE SMALL CAP -2.8% -11.4% 10%
S&P BSE 250 SMALLCAP -2.9% -12.2% 6%
NSE Indices1W1M1Y
NIFTY 500 -0.2% -6.9% 7%
NIFTY500 MULTICAP 50:25:25 -0.8% -8.3% 7.2%
NIFTY MID SMALL400 -1.5% -9.7% 7.3%
NIFTY SMALLCAP250 -3% -12.7% 6.4%

You may also like the below Video Courses


FAQ about THYROCARE TECHNOLOGIES


Is THYROCARE TECHNOLOGIES good for long term investment?

As on May 27,2022, the Fundamentals of THYROCARE TECHNOLOGIES look Strong and hence it may be good for long term investment! See Financial Performance of THYROCARE TECHNOLOGIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is THYROCARE TECHNOLOGIES UnderValued or OverValued?

As on May 27,2022, THYROCARE TECHNOLOGIES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of THYROCARE TECHNOLOGIES ?

As on May 27,2022, the Intrinsic Value of THYROCARE TECHNOLOGIES is Rs. 1,087.08 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 709.10
Fair Value [Median EV / Sales Model] : Rs. 1,087.08
Fair Value [Median Price / Sales Model] : Rs. 1,229.42
Median Fair Value of THYROCARE TECHNOLOGIES : Rs. 1,087.08

Is THYROCARE TECHNOLOGIES trading at a Premium or Discount?

As on May 27,2022, THYROCARE TECHNOLOGIES is trading at a Discount of -36% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z